Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Clinical trial NCT06869239 · RECRUITING
Trial details
- NCT number
- NCT06869239
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-25
- Primary completion
- 2027-01-03
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.